WEED Inc. Acquires Hempirical Genetics, With Over 250 Proprietary Cannabis & Hemp Strains For $750K

WEED, Inc. (OTCQB:BUDZ) a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and anima

Benzinga Real-time NewsJul 21, 2022 08:00 ET

WEED acquires Hempirical Genetics for $750K

WEED (OTCPK:BUDZ) said Wednesday it acquired Hempirical Genetics for $750K. The deal amount includes 2M shares valued at $0.25/share and $250K in cash over 4 years. BUDZ paid 1M shares and $10K on sig

Seeking AlphaJul 20, 2022 13:11 ET

Is Weed Inc (BUDZ) Stock a Smart Value?

Weed Inc (BUDZ) stock is lower by -63.38% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives BUDZ stock a score of 9 out of a possible 100. That rank is mainly influenced by a fundamental score of

InvestorsObserverApr 5, 2022 16:22 ET

Is Weed Inc (BUDZ) a Poor Choice in the Healthcare Sector?

Weed Inc (BUDZ) is around the bottom of the Healthcare sector according to InvestorsObserver. BUDZ received an overall rating of 14, which means that it scores higher than 14% of s

InvestorsObserverMar 30, 2022 16:21 ET

Can Weed Inc (BUDZ) Stock Rise to the Top of Healthcare Sector Friday?

Weed Inc (BUDZ) is near the bottom in its sector according to InvestorsObserver. BUDZ gets an overall rating of 6. That means it scores higher than 6% of stocks. Weed Inc gets a 2 rank in the Healthcare sector.

InvestorsObserverMar 18, 2022 16:07 ET

Is Weed Inc (BUDZ) Stock a Smart Investment Wednesday?

Weed Inc (BUDZ) stock is down -80.43% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives BUDZ stock a score of 11 out of a possible 100. That rank is primarily influenced by a fundamental score of

InvestorsObserverMar 16, 2022 15:26 ET